Methadone dose and neonatal abstinence syndrome-systematic review and meta-analysis.
AuthorsCleary, Brian J
Gallagher, Paul J
Murphy, Deirdre J
AffiliationCoombe Women and Infants University Hospital, Dublin 8, Ireland School of, Pharmacy, Royal College of Surgeons in Ireland, Dublin 2, Ireland., firstname.lastname@example.org
Dose-Response Relationship, Drug
Methadone/*administration & dosage/adverse effects
Narcotics/*administration & dosage/adverse effects
Neonatal Abstinence Syndrome/*epidemiology/etiology
Opioid-Related Disorders/*drug therapy
Pregnancy Complications/*drug therapy
Prenatal Exposure Delayed Effects
Randomized Controlled Trials as Topic
Severity of Illness Index
MetadataShow full item record
CitationAddiction. 2010 Dec;105(12):2071-84. doi: 10.1111/j.1360-0443.2010.03120.x. Epub , 2010 Sep 15.
JournalAddiction (Abingdon, England)
AbstractAIM: To determine if there is a relationship between maternal methadone dose in pregnancy and the diagnosis or medical treatment of neonatal abstinence syndrome (NAS). METHODS: PubMed, EMBASE, the Cochrane Library and PsychINFO were searched for studies reporting on methadone use in pregnancy and NAS (1966-2009). The relative risk (RR) of NAS was compared for methadone doses above versus below a range of cut-off points. Summary RRs and 95% confidence intervals (CI) were estimated using random effects meta-analysis. Sensitivity analyses explored the impact of limiting meta-analyses to prospective studies or studies using an objective scoring system to diagnose NAS. RESULTS: A total of 67 studies met inclusion criteria for the systematic review; 29 were included in the meta-analysis. Any differences in the incidence of NAS in infants of women on higher compared with lower doses were statistically non-significant in analyses restricted to prospective studies or to those using an objective scoring system to diagnose NAS. CONCLUSIONS: Severity of the neonatal abstinence syndrome does not appear to differ according to whether mothers are on high- or low-dose methadone maintenance therapy.
- Higher maternal doses of methadone does not increase neonatal abstinence syndrome.
- Authors: Pizarro D, Habli M, Grier M, Bombrys A, Sibai B, Livingston J
- Issue date: 2011 Apr
- Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome.
- Authors: Seligman NS, Almario CV, Hayes EJ, Dysart KC, Berghella V, Baxter JK
- Issue date: 2010 Sep
- Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
- Authors: Bakstad B, Sarfi M, Welle-Strand GK, Ravndal E
- Issue date: 2009
- Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome.
- Authors: Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA
- Issue date: 2010 Dec
- Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
- Authors: Gaalema DE, Scott TL, Heil SH, Coyle MG, Kaltenbach K, Badger GJ, Arria AM, Stine SM, Martin PR, Jones HE
- Issue date: 2012 Nov